In the production of chemical factories and pharmaceutical preparations, the stability control of acetylcysteine preparations is the core for ensuring the efficacy and quality of the products. It requires multiple measures to maintain the stability of the preparations within the effective period. The primary measure for stability control of acetylcysteine preparations is the optimization of the formulation design. In the formulation, suitable excipients with good compatibility with acetylcysteine should be selected, and components that are prone to oxidation reactions with chemical factories’ acetylcysteine should be avoided. At the same time, appropriate antioxidants (such as vitamin C) and pH regulators should be added to control the pH value of the preparation within the optimal range of 4.0-6.0, thereby reducing the degradation of acetylcysteine due to an inappropriate acid-base environment and laying the foundation for the preparation’s stability.
Environmental control during the chemical factories’ production process is the key link in the stability control of acetylcysteine preparations. Acetylcysteine is easily oxidized; therefore, its production should be carried out in a low-oxygen, light-protected, and clean environment. The production workshop needs to control the oxygen concentration to be lower than 5%, and use light-protective lighting and light-protective equipment to avoid direct sunlight causing the degradation of acetylcysteine. Mixing, granulation, filling, and other operations should be carried out quickly and continuously to shorten the time that acetylcysteine is in contact with the air; During the production process, the moisture content of the preparation should be monitored in real time to avoid excessive moisture accelerating the hydrolysis of acetylcysteine and ensuring that the production process does not affect the stability of the preparation.
The selection of packaging materials is an important supplement to the stability control of chemical factories’ acetylcysteine preparations. According to the formulation type, packaging materials with good sealing, light-protective, and oxygen-blocking properties should be selected, such as brown light-protective glass bottles for oral liquid preparations and aluminum-plastic blister packaging for solid preparations with an oxygen-blocking film added inside. The packaging materials need to undergo compatibility tests to confirm that they will not react with acetylcysteine or release harmful substances. During the packaging process, vacuum pumping or inert gas (such as nitrogen) should be injected to reduce the oxygen content in the packaging, preventing acetylcysteine from being oxidized during storage and extending the preparation’s effective period.
Storage condition management is the concluding measure for the stability control of acetylcysteine preparations. Acetylcysteine preparations need to be stored in a cool, light-protected, and dry warehouse, with a storage temperature controlled at 2-8℃ (for liquid preparations) or 10-30℃ (for solid preparations), and a relative humidity not exceeding 60%. During storage, stability examinations should be conducted regularly to detect the content, pH value, appearance, etc. of the preparation, and record the changes. If any problems, such as discoloration, odor, or content reduction, are found in the preparation, it should be immediately stopped from use and the cause analyzed to ensure the stability of the acetylcysteine preparation throughout the storage period.
The stability control of acetylcysteine preparations runs through the entire process of formulation design, production, packaging, and storage, and strict control at each stage directly affects the stability of the preparation. Through scientific control measures, the degradation of acetylcysteine can be effectively reduced, ensuring the efficacy and quality of the preparation within the effective period, meeting the clinical medication requirements, and conforming to the quality standards of the pharmaceutical chemical factories.